These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Kellar KJ, Whitehouse PJ, Martino-Barrows AM, Marcus K, Price DL. Brain Res; 1987 Dec 08; 436(1):62-8. PubMed ID: 3690354 [Abstract] [Full Text] [Related]
3. Reductions in acetylcholine and nicotine binding in several degenerative diseases. Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ. Arch Neurol; 1988 Jul 08; 45(7):722-4. PubMed ID: 3390025 [Abstract] [Full Text] [Related]
4. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R. J Neurochem; 1988 Jun 08; 50(6):1914-23. PubMed ID: 3373218 [Abstract] [Full Text] [Related]
5. Reduced number of [3H]nicotine and [3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Nordberg A, Winblad B. Neurosci Lett; 1986 Dec 03; 72(1):115-9. PubMed ID: 3808458 [Abstract] [Full Text] [Related]
6. Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. Flynn DD, Mash DC. J Neurochem; 1986 Dec 03; 47(6):1948-54. PubMed ID: 3772387 [Abstract] [Full Text] [Related]
8. Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ. Neurology; 1988 May 03; 38(5):720-3. PubMed ID: 3362368 [Abstract] [Full Text] [Related]
9. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. J Neurochem; 1992 Feb 03; 58(2):529-41. PubMed ID: 1729398 [Abstract] [Full Text] [Related]
15. Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. Sugaya K, Giacobini E, Chiappinelli VA. J Neurosci Res; 1990 Nov 03; 27(3):349-59. PubMed ID: 2097379 [Abstract] [Full Text] [Related]
16. Does apolipoprotein E (Apo-E) genotype influence nicotinic receptor binding in Alzheimer's disease. Reid RT, Sabbagh MN, Thal LJ. J Neural Transm (Vienna); 2001 Nov 03; 108(8-9):1043-50. PubMed ID: 11716140 [Abstract] [Full Text] [Related]
17. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Court JA, Piggott MA, Lloyd S, Cookson N, Ballard CG, McKeith IG, Perry RH, Perry EK. Neuroscience; 2000 Nov 03; 98(1):79-87. PubMed ID: 10858614 [Abstract] [Full Text] [Related]